Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · IEX Real-Time Price · USD
33.56
+1.09 (3.36%)
At close: Apr 26, 2024, 4:00 PM
30.24
-3.32 (-9.89%)
After-hours: Apr 26, 2024, 6:26 PM EDT
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $1.21 billion as of April 26, 2024. Its market cap has increased by 11,454.52% in one year.
Market Cap
1.21B
Enterprise Value
873.63M
1-Year Change
11,454.52%
Ranking
Category
Stock Price
$33.56
Market Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $1.21B, an increase of 986.15%. That is a compound annual growth rate of 34.45%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 26, 2024 | 1.21B | 3.36% |
Apr 25, 2024 | 1.17B | -1.58% |
Apr 24, 2024 | 1.19B | -3.68% |
Apr 23, 2024 | 1.24B | 2.87% |
Apr 22, 2024 | 1.20B | 2.72% |
Apr 19, 2024 | 1.17B | -8.91% |
Apr 18, 2024 | 1.29B | 3.71% |
Apr 17, 2024 | 1.24B | -5.41% |
Apr 16, 2024 | 1.31B | -2.50% |
Apr 15, 2024 | 1.34B | -0.77% |
Apr 12, 2024 | 1.36B | -2.85% |
Apr 11, 2024 | 1.40B | -0.26% |
Apr 10, 2024 | 1.40B | -1.25% |
Apr 9, 2024 | 1.42B | 5.52% |
Apr 8, 2024 | 1.34B | 2.63% |
Apr 5, 2024 | 1.31B | 2.26% |
Apr 4, 2024 | 1.28B | 2.08% |
Apr 3, 2024 | 1.25B | 1.02% |
Apr 2, 2024 | 1.24B | -7.27% |
Apr 1, 2024 | 1.34B | -2.45% |
Mar 28, 2024 | 1.37B | 2.51% |
Mar 27, 2024 | 1.34B | -1.62% |
Mar 26, 2024 | 1.36B | -2.26% |
Mar 25, 2024 | 1.39B | -6.60% |
Mar 22, 2024 | 1.49B | 3.36% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
4D Molecular Therapeutics | 1.24B |
Tarsus Pharmaceuticals | 1.23B |
Verona Pharma | 1.23B |
Phreesia | 1.22B |
Pacira BioSciences | 1.20B |
Deciphera Pharmaceuticals | 1.18B |
Xencor | 1.16B |
AbCellera Biologics | 1.14B |